Proventil and Mesalamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Proventil (albuterol) and Mesalamine (mesalamine). Common drug interactions include drug hypersensitivity among females and abdominal abscess among males.

The phase IV clinical study analyzes what interactions people have when they take Proventil and Mesalamine. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Proventil?

Proventil has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 16,110 Proventil users. Check the latest studies of Proventil.

What is Mesalamine?

Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.



On Jul, 08, 2026

12 people who take Proventil and Mesalamine together, and have interactions are studied.

Proventil and Mesalamine drug interactions.

What are the common drug interactions of Proventil and Mesalamine, by gender? *:

female:

  1. Drug hypersensitivity
  2. Carotid artery disease
  3. Glycosylated haemoglobin increased
  4. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Contrast media allergy (reaction associated with the use of intravenous contrast material during radiology)
  7. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  8. Diarrhoea
  9. Dizziness
  10. Hypoaesthesia (reduced sense of touch or sensation)

male:

  1. Abdominal abscess (collection of pus in abdomen)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Joint dislocation (a joint position is changed from normal position)
  4. Multiple fractures
  5. Osteonecrosis (death of bone)
  6. Osteoporosis (bones weak and more likely to break)
  7. Pain
  8. Pain in jaw
  9. Tooth loss
  10. Anxiety

What are the common drug interactions of Proventil and Mesalamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal abscess (collection of pus in abdomen)
  2. Fistula (an abnormal connection or passageway between two)
  3. Joint dislocation (a joint position is changed from normal position)
  4. Multiple fractures
  5. Osteoporosis (bones weak and more likely to break)

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone density decreased
  4. Bone loss
  5. Chronic kidney disease
  6. Emotional distress
  7. Fracture
  8. Osteonecrosis (death of bone)
  9. Pain
  10. Tooth loss

40-49:

  1. Drug hypersensitivity
  2. Contrast media allergy (reaction associated with the use of intravenous contrast material during radiology)
  3. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  4. Iodine allergy

50-59:

  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Carotid artery disease
  3. Glycosylated haemoglobin increased
  4. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

60+:

  1. Diarrhoea
  2. Dizziness
  3. Fatigue (feeling of tiredness)
  4. Nausea (feeling of having an urge to vomit)
  5. Pain in jaw
  6. Urticaria (rash of round, red welts on the skin that itch intensely)

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 4 people, 33.33%
  2. Stress And Anxiety: 3 people, 25.00%
  3. Sinus Headache (headache caused by sinus infections): 3 people, 25.00%
  4. Constipation: 3 people, 25.00%
  5. Cough: 3 people, 25.00%
  6. Cystitis Interstitial (unknown cause characterized by bladder pain): 3 people, 25.00%
  7. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 25.00%
  8. Fungal Infection: 3 people, 25.00%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%
  10. Headache (pain in head): 3 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Proventil and Mesalamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Proventil and Mesalamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Proventil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mesalamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proventil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mesalamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on albuterol and mesalamine (the active ingredients of Proventil and Mesalamine, respectively), and Proventil and Mesalamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: